Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 2 |
2020 | 3 |
2021 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The amino acid transporter SLC7A11 expression in breast cancer.
Cancer Biol Ther. 2024 Dec 31;25(1):2291855. doi: 10.1080/15384047.2023.2291855. Epub 2023 Dec 10.
Cancer Biol Ther. 2024.
PMID: 38073087
Free PMC article.
SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer.
Alfarsi LH, El Ansari R, Craze ML, Mohammed OJ, Masisi BK, Ellis IO, Rakha EA, Green AR.
Alfarsi LH, et al.
Breast Cancer Res Treat. 2021 Sep;189(2):317-331. doi: 10.1007/s10549-021-06298-1. Epub 2021 Jul 19.
Breast Cancer Res Treat. 2021.
PMID: 34282517
Free PMC article.
Item in Clipboard
PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer.
Alfarsi LH, El Ansari R, Craze ML, Masisi BK, Ellis IO, Rakha EA, Green AR.
Alfarsi LH, et al.
BMC Cancer. 2020 May 14;20(1):425. doi: 10.1186/s12885-020-06939-6.
BMC Cancer. 2020.
PMID: 32410585
Free PMC article.
Item in Clipboard
Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.
Alfarsi LH, El-Ansari R, Craze ML, Masisi BK, Mohammed OJ, Ellis IO, Rakha EA, Green AR.
Alfarsi LH, et al.
Int J Mol Sci. 2020 Feb 19;21(4):1407. doi: 10.3390/ijms21041407.
Int J Mol Sci. 2020.
PMID: 32093034
Free PMC article.
Item in Clipboard
CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
Alfarsi LH, Ansari RE, Craze ML, Toss MS, Masisi B, Ellis IO, Rakha EA, Green AR.
Alfarsi LH, et al.
Breast Cancer Res Treat. 2019 Dec;178(3):535-544. doi: 10.1007/s10549-019-05420-8. Epub 2019 Aug 30.
Breast Cancer Res Treat. 2019.
PMID: 31471836
Item in Clipboard
Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
Alfarsi LH, Elansari R, Toss MS, Diez-Rodriguez M, Nolan CC, Ellis IO, Rakha EA, Green AR.
Alfarsi LH, et al.
Breast Cancer Res Treat. 2019 Jan;173(1):93-102. doi: 10.1007/s10549-018-4978-5. Epub 2018 Oct 10.
Breast Cancer Res Treat. 2019.
PMID: 30306428
Item in Clipboard
Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer.
Alfarsi LH, El Ansari R, Masisi BK, Parks R, Mohammed OJ, Ellis IO, Rakha EA, Green AR.
Alfarsi LH, et al.
Cancers (Basel). 2020 Jun 12;12(6):1549. doi: 10.3390/cancers12061549.
Cancers (Basel). 2020.
PMID: 32545448
Free PMC article.
Item in Clipboard
Cite
Cite